CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myelomaTobias Bexte, Evelyn Ullrich, Jamal Alzubi et al.|OncoImmunology|2022Cited by 77